Tables

Table 2.1 Field meter characteristics

Table 2.2 Magnetic field exposure metrics used in epidemiological studies

Table 2.3 Standard occupational classification codes and job categories of "electrical jobs"

Table 2.4 Electrical occupations derived from job titles with TWA magnetic field exposures

Table 2.5 Occupational exposure measurements in occupational studies

Table 2.6 Distribution of wire code categories of control subjects' homes in seven studies in the USA

Table 2.7 Measured magnetic fields and Wertheimer-Leeper wire codes in six studies in the USA

Table 2.8 Comparison of the percentage of homes in wire code categories > 0.2 or 0.3 µT in four studies in the USA

Table 2.9 Estimated median magnetic fields in the 1000 homes survey

Table 2.10 Average magnetic flux densities in schools in Canada 45

Table 2.11 Magnetic fields associated with use of appliances 47

Table 3.1 Typical average electric fields in bone marrow in numerical dosimetric studies of uniform conditions of exposure to electric or magnetic fields at 60 Hz 80

Table 3.2 Calculated average induced electric fields in selected tissues in a human adult from a 1.0 µT, 60 Hz magnetic field orientated from shoulders and assumed tissue conductivities 81

Table 4.1 Results of long term chronic bioassays in rodents exposed to EMF 103

Table 4.2 Assays of co-initiation and of promotion of: mammary cancer 104

Table 4.3 Incidences of mammary gland lesions in female rats exposed to 10 mg DMBA plus sham exposure or exposure to magnetic fields 94

Table 4.4 Studies of promotion and co-promotion of skin cancer 105

Table 4.5 Studies of promotion and co-promotion of liver cancer 106

Table 4.6 Studies of promotion of: Lymphoma/leukemia 106

Table 4.7 Lymphoma incidence in mice treated with ionizing radiation and EMF 99

Table 4.8 Leukemia/lymphoma in transgenic mice exposed to 60 Hz magnetic fields 101

Table 4.9 Minimal exposure assessment required for a study to be included in this review 109

Table 4.10 Epidemiological studies of exposure to EMF and cancer at all sites 146

Table 4.11 Epidemiological studies of leukemia with full-shift measurements of magnetic fields 147

Table 4.12 Epidemiological studies of brain cancer with full-shift measurements of magnetic fields 151

Table 4.13 Cohort studies of breast cancer and occupational exposure to EMF 154

Table 4.14 Case-control studies of male breast cancer and occupational exposure to EMF 155

Table 4.15 Case-control studies of female breast cancer and occupational studies of EMF 157

Table 4.16 Epidemiological studies of lung cancer with full-shift measurements of magnetic fields 158

Table 4.17 Central nervous system tumors in offspring of EMF-exposed parents 159

Table 4.18 Design of studies of leukemia and residential exposure to EMF 161

Table 4.19 Results of studies of leukemia and residential exposure to EMF 164

Table 4.20 Summary of epidemiological studies on childhood cancers 190

Table 4.21 Childhood leukemia 196

Table 4.22 Results for childhood nervous system tumors 200

Table 4.23 Results for childhood lymphoma 202

Table 4.24 Summary of appliance studies 203

Table 4.25 Summary of meta-analysis results 205

Table 4.26 Summary of NIEHS meta-analysis 207

Table 4.27 Summary of immunological studies of exposure to EMF in experimental animals 213

Table 4.28 Perception in experimental animals exposed to EMF 230

Table 4.29 Summary of experiments assessing aversion in experimental animals fields 231

Table 4.30 Learning and performance in experimental animals exposed to EMF 232

Table 4.31 Neurophysiological effects of EMF in experimental animals 234

Table 4.32 Electrophysiological effects of EMF in experimental animals 236

Table 4.33 Studies on EMF exposures and reproductive and developmental effects of EMF in experimental animals and birds 241

Table 4.34 Studies of the effect of exposure to EMF on melatonin in experimental animals 253

Table 4.35 Minimal exposure assessment required for a study to be included in this review 272

Table 4.36 Adverse pregnancy outcomes and maternal exposure to EMF 293

Table 4.37 Alzheimer disease and dementia in association with exposure to EMF 295

Table 4.38 Amyotrophic lateral sclerosis in association with exposure to EMF 297

Table 4.39 Suicide and depression in association with exposure to EMF 299

Table 4.40 Mortality from cardiovascular disease in relation to exposure to magnetic fields (Savitz et al., 1998c) 300

Table 4.41 Effects on exposure to EMF on measures of electrical activity in human brain 318

Table 4.42 Laboratory studies of the effects of magnetic fields on electroencephalographic measures of human sleep 320

Table 4.43 EMF effects of exposure to EMF on human cognition and performance 321

Table 4.44 Effects of exposure to EMF on heart rate and heart rate variability in human volunteers 323

Table 4.45 Effects of exposure to EMF on melatonin and its metabolite in humans 324

Table 4.46 Maximum numbers of turnovers of some enzymes 391

Table 4.47 Cells showing Ca++ oscillations 391

Table 4.48 Average endogenous fields due to heart activity induced field (Hz) 391

Table 4.49 Experimental papers reporting resonance depending on the static magnetic fields (BDC) 392

Table 8.1 Units 477